Allison E Ashley-Koch1, Melanie E Garrett2, Jason Gibson2, Yutao Liu2, Michelle F Dennis3, Nathan A Kimbrel3, Jean C Beckham3, Michael A Hauser2. 1. Department of Medicine, Duke University Medical Center, Durham, NC, United States. Electronic address: allison.ashleykoch@duke.edu. 2. Department of Medicine, Duke University Medical Center, Durham, NC, United States. 3. Durham Veterans Affairs Medical Center, Durham, NC, United States; The VA Mid-Atlantic Mental Illness Research, Education, and Clinical Center, Durham, NC, United States; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, United States.
Abstract
BACKGROUND: Posttraumatic stress disorder (PTSD) is a psychiatric disorder that can develop after experiencing traumatic events. A genome-wide association study (GWAS) design was used to identify genetic risk factors for PTSD within a multi-racial sample primarily composed of U.S. veterans. METHODS: Participants were recruited at multiple medical centers, and structured interviews were used to establish diagnoses. Genotypes were generated using three Illumina platforms and imputed with global reference data to create a common set of SNPs. SNPs that increased risk for PTSD were identified with logistic regression, while controlling for gender, trauma severity, and population substructure. Analyses were run separately in non-Hispanic black (NHB; n = 949) and non-Hispanic white (NHW; n = 759) participants. Meta-analysis was used to combine results from the two subsets. RESULTS: SNPs within several interesting candidate genes were nominally significant. Within the NHB subset, the most significant genes were UNC13C and DSCAM. Within the NHW subset, the most significant genes were TBC1D2, SDC2 and PCDH7. In addition, PRKG1 and DDX60L were identified through meta-analysis. The top genes for the three analyses have been previously implicated in neurologic processes consistent with a role in PTSD. Pathway analysis of the top genes identified alternative splicing as the top GO term in all three analyses (FDR q < 3.5 × 10(-5)). LIMITATIONS: No individual SNPs met genome-wide significance in the analyses. CONCLUSIONS: This multi-racial PTSD GWAS identified biologically plausible candidate genes and suggests that post-transcriptional regulation may be important to the pathology of PTSD; however, replication of these findings is needed.
BACKGROUND:Posttraumatic stress disorder (PTSD) is a psychiatric disorder that can develop after experiencing traumatic events. A genome-wide association study (GWAS) design was used to identify genetic risk factors for PTSD within a multi-racial sample primarily composed of U.S. veterans. METHODS:Participants were recruited at multiple medical centers, and structured interviews were used to establish diagnoses. Genotypes were generated using three Illumina platforms and imputed with global reference data to create a common set of SNPs. SNPs that increased risk for PTSD were identified with logistic regression, while controlling for gender, trauma severity, and population substructure. Analyses were run separately in non-Hispanic black (NHB; n = 949) and non-Hispanic white (NHW; n = 759) participants. Meta-analysis was used to combine results from the two subsets. RESULTS: SNPs within several interesting candidate genes were nominally significant. Within the NHB subset, the most significant genes were UNC13C and DSCAM. Within the NHW subset, the most significant genes were TBC1D2, SDC2 and PCDH7. In addition, PRKG1 and DDX60L were identified through meta-analysis. The top genes for the three analyses have been previously implicated in neurologic processes consistent with a role in PTSD. Pathway analysis of the top genes identified alternative splicing as the top GO term in all three analyses (FDR q < 3.5 × 10(-5)). LIMITATIONS: No individual SNPs met genome-wide significance in the analyses. CONCLUSIONS: This multi-racial PTSD GWAS identified biologically plausible candidate genes and suggests that post-transcriptional regulation may be important to the pathology of PTSD; however, replication of these findings is needed.
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters Journal: Arch Gen Psychiatry Date: 2005-06
Authors: Ilan Wald; Kathryn A Degnan; Elena Gorodetsky; Dennis S Charney; Nathan A Fox; Eyal Fruchter; David Goldman; Gad Lubin; Daniel S Pine; Yair Bar-Haim Journal: JAMA Psychiatry Date: 2013-04 Impact factor: 21.596
Authors: Dean G Kilpatrick; Karestan C Koenen; Kenneth J Ruggiero; Ron Acierno; Sandro Galea; Heidi S Resnick; John Roitzsch; John Boyle; Joel Gelernter Journal: Am J Psychiatry Date: 2007-11 Impact factor: 18.112
Authors: Caroline M Nievergelt; Adam X Maihofer; Maja Mustapic; Kate A Yurgil; Nicholas J Schork; Mark W Miller; Mark W Logue; Mark A Geyer; Victoria B Risbrough; Daniel T O'Connor; Dewleen G Baker Journal: Psychoneuroendocrinology Date: 2014-10-30 Impact factor: 4.693
Authors: Nikolaos P Daskalakis; Chuda M Rijal; Christopher King; Laura M Huckins; Kerry J Ressler Journal: Curr Psychiatry Rep Date: 2018-04-05 Impact factor: 5.285
Authors: Krishnan Radhakrishnan; Mihaela Aslan; Kelly M Harrington; Robert H Pietrzak; Grant Huang; Sumitra Muralidhar; Kelly Cho; Rachel Quaden; David Gagnon; Saiju Pyarajan; Ning Sun; Hongyu Zhao; Michael Gaziano; John Concato; Murray B Stein; Joel Gelernter Journal: Int J Methods Psychiatr Res Date: 2019-02-14 Impact factor: 4.035
Authors: Celia van der Merwe; Neda Jahanshad; Josh W Cheung; Mary Mufford; Nynke A Groenewold; Nastassja Koen; Rajkumar Ramesar; Shareefa Dalvie; James A Knowles; Derrek P Hibar; Caroline M Nievergelt; Karestan C Koenen; Israel Liberzon; Kerry J Ressler; Sarah E Medland; Rajendra A Morey; Paul M Thompson; Dan J Stein Journal: J Affect Disord Date: 2018-11-13 Impact factor: 4.839
Authors: Sandra M Meier; Kalevi Trontti; Kirstin L Purves; Thomas Damm Als; Jakob Grove; Mikaela Laine; Marianne Giørtz Pedersen; Jonas Bybjerg-Grauholm; Marie Bækved-Hansen; Ewa Sokolowska; Preben B Mortensen; David M Hougaard; Thomas Werge; Merete Nordentoft; Gerome Breen; Anders D Børglum; Thalia C Eley; Iiris Hovatta; Manuel Mattheisen; Ole Mors Journal: JAMA Psychiatry Date: 2019-09-01 Impact factor: 21.596
Authors: Caroline M Nievergelt; Allison E Ashley-Koch; Shareefa Dalvie; Michael A Hauser; Rajendra A Morey; Alicia K Smith; Monica Uddin Journal: Biol Psychiatry Date: 2018-02-02 Impact factor: 13.382
Authors: Nathan A Kimbrel; Melanie E Garrett; Michelle F Dennis; Michael A Hauser; Allison E Ashley-Koch; Jean C Beckham Journal: Psychiatry Res Date: 2018-07-17 Impact factor: 3.222
Authors: Murray B Stein; Erin B Ware; Colter Mitchell; Chia-Yen Chen; Susan Borja; Tianxi Cai; Catherine L Dempsey; Carol S Fullerton; Joel Gelernter; Steven G Heeringa; Sonia Jain; Ronald C Kessler; James A Naifeh; Matthew K Nock; Stephan Ripke; Xiaoying Sun; Jean C Beckham; Nathan A Kimbrel; Robert J Ursano; Jordan W Smoller Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2017-09-13 Impact factor: 3.568